血清肿瘤分子标志物:从挖掘到临床应用  

Serum molecular tumor markers:from mining to clinical application

作　　者：张玉娟 崔巍 Zhang Yujuan;Cui Wei(State Key Laboratory of Molecular Oncology,Department of Clinical Laboratory,National Cancer Center,National Clinical Research Center for Cancer,Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China)

机构地区：[1]国家癌症中心国家肿瘤临床医学研究中心,中国医学科学院北京协和医学院肿瘤医院检验科,北京100021

出　　处：《中华检验医学杂志》2021年第6期470-471,共2页Chinese Journal of Laboratory Medicine

摘　　要：近年来,分子诊断技术日新月异,伴随而来的分子标志物在肿瘤的预防、诊断、治疗、预后评估、复发监测等中应用研究也越来越多,但各种实验室技术和分子标志物具有各自的优势和局限性,如何选择适宜的实验技术和恰当的血清肿瘤分子标志物是临床实践中的关注热点。In recent years,with the rapid development of molecular diagnostic technology,more and more serum molecular tumor markers have been found and been used in the tumor prevention,diagnosis,treatment,prognosis assessment and relapse monitoring.However,each laboratory techniques and molecular markers has its own advantages and limitations.How to choose the appropriate laboratory technology and tumor markers is a hot topic in clinical practice.

关 键 词：肿瘤 分子 指标 临床实验室技术 

分 类 号：R730.43[医药卫生—肿瘤]